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I.

EXECUTIVE SUMMARY

Proposition 14 authorizes the state to sell $5.5 billion in general obligation bonds to
support stem cell and other medical research, updating and renewing the program
approved by voters in 2004. The research is aimed at developing treatments and cures for
serious diseases and conditions like diabetes, cancer, HIV/AIDs, heart disease, paralysis,
blindness, kidney disease, respiratory illnesses, and many more. Of the $5.5 billion, $1.5
billion will be dedicated to the support of research and the development of treatments for
diseases and conditions of the brain and central nervous system, such as Alzheimer’s
disease, Parkinson’s disease, stroke, dementia, epilepsy, depression, brain cancer,
schizophrenia, autism, and other diseases and conditions of the brain. If the proposition
passes, the estimated cost to taxpayers over time will be $7.8 billion.1
II.

THE LAW
A. Existing Law

In 2004, California voters approved Proposition 71, which added a provision to the
State Constitution affirming the right of researchers in California to conduct stem cell
research.2 Proposition 71 also created the California Institute for Regenerative Medicine
(CIRM) to provide grants to universities and other entities in California to support stem cell
research, development of new treatments, clinical trials, new research facilities, and other
related activities.3 The measure also established a governing board to adopt CIRM policies
and allocate funds, three advisory working groups to help guide the governing board, and
an independent oversight committee to review CIRM’s finances.4
These grants were funded by $3 billion through the sale of public bonds; and the
interest, another $3 billion, was payable from the state’s General Fund.5 As of June 2020,
around $30 million remains available for grants.6 In the event that Proposition 14 does not
pass, CIRM has been decreasing staff and plans to maintain only those needed to manage
remaining projects until they are completed.7
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B. Relevant Peripheral Legislation
1. California State Law
California state law permits research on human embryonic stem cells, human
embryonic germ cells, and human adult stem cells including somatic cell nuclear
transplantation, that has been reviewed by a stem cell research oversight committee.8 This
research is subject to the laws relating to the donation of tissue and the storage of
embryos.9 California state law prohibits human reproductive cloning, however human
reproductive cloning is not the same as embryonic stem cell research.10 Human
reproductive cloning requires placing the embryos back into a uterine environment while
embryonic stem cells are studied in a laboratory environment.11
2. Federal Law
On March 9, 2009, President Obama issued an executive order, “Removing Barriers
to Responsible Scientific Research Involving Human Stem Cells.”12 This executive order
removed limitations placed on research involving human embryonic stem cells created by
President G.W. Bush in August 2001.13
On June 5, 2019, the Trump administration announced that it will no longer allow
government scientists working for the National Institutes of Health (NIH) to conduct studies
that use fetal tissue, and university scientists seeking NIH funding for such studies must now
have each proposal examined by an ethics advisory board.14 The board would be made up
of 14 to 20 people from various backgrounds, including at least one theologian, one
ethicist, one physician, and one attorney.15 No more than half of the panel members can be
scientists.16 Even though this is not directly related to stem cell research, it provides a
glimpse into possible future restrictions that may arise if this administration remains in
office.
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3. Other States
Nearly a dozen states have launched initiatives for funding stem cell research,
though they have not contributed as much money as California.17 Like California, some
states allocated funding to support stem cell research in response to the restrictions on
federal funding by the Bush administration, including Maryland and New York.18 In 2006,
Maryland passed the Maryland Stem Cell Act of 2006 and to date has awarded $165
million to promote state funded stem cell research through the Maryland Stem Cell
Research Fund.19 Similarly, in 2007, New York launched the New York State Stem Cell
Science program (NYSTEM) to support stem cell research across the state of New York.20 To
date, NYSTEM has awarded $396 million to New York institutions.21
C. Current Funding and Revenue
1. Funding
A variety of sources fund stem cell research in California. These sources include: the
federal government’s National Institutes of Health, private investors, and CIRM, each having
different goals and abilities.22
Private sector investment generally occurs during the testing and development
phase, rather than the initial basic research.23 Scientists have referred to the stage right
before industry becomes interested in the research as the “Valley of Death.”24 It is an area
where promising therapies often languish, because there is not enough federal funding to
push the projects through to the later stages.25 CIRM has focused on funding the early
research that leads to therapy ideas and fund projects that are in the Valley of Death
stage, helping to keep good projects on track toward clinical therapies.26
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CIRM has spent nearly all of its available funds.27 The bonds issued under
Proposition 71 comprised nearly all of CIRM’s funding, with a relatively small amount of
funding from investment income, private donations, or other sources.28 As of June 2020,
CIRM had $30 million remaining for grants, and it has decreased its staff from a peak of 50
full-time staff to 35 full-time staff, planning to maintain some staff while the remaining
projects are completed.29
On the federal level, NIH awards grants to fund research nationwide and has a
budget of $40.3 billion for medical research in 2020.30 More than 80% of NIH’s funding is
dispersed through competitive grants to research institutions across the nation and $2.1
billion will go towards stem cell research in 2020.31
2. Revenue
Economists at the University of Southern California conducted an economic impact
study of CIRM in October 2019.32 This study estimated that CIRM has added $15.4 billion
into the U.S. economy over 14 years.33 The estimates are based on economic stimulus
created by CIRM grants; co-funding; partnership funding; leverage funding of Alpha Stem
Cell Clinics, follow-on funding, and CIRM operating expenditures.34 This study was funded by
CIRM.
a) Estimated Economic Impacts on California Economy
CIRM-funded activities added to the California economy $10.7 billion in scientific
research and development services, real estate, construction, hospitals, food manufacturing,
wholesale trade, professional and health care services, and rental and leasing services.35
These activities increased state and local tax revenues by $434.1 million between 2005 and
2018.36 Even if Proposition 14 does not pass, CIRM is still estimated to increase state and
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local tax revenues by an additional $207.2 million through 2023.37 Additionally, CIRM
created roughly 44,010 full-time equivalent jobs between 2005 and 2018, half of which offer
salaries higher than the state average.38 By 2023, that number is expected to increase to
56,549.39
b) Estimated Economic Impacts on the Rest of U.S.
The quantified impact on the rest of the U.S. economy through 2023 is an estimated
increase of $4.7 billion in gross outcome.40 Additionally, federal taxes from CIRM-related
activities are estimated to have increased by $726.6 million while adding an additional
25,816 jobs nationwide.41
D. Relevant Litigation
After voters approved Proposition 71, the California Family Bioethics Council
challenged its constitutionality.42 In this case, the opponents made four allegations.43 First,
they alleged that the initiative violated California’s single-subject requirement for initiatives
because some of the provisions of the proposition covered more than stem cell research.44
Second, they alleged that the Proposition 71 ballot materials were misleading in a way that
violated due process of law.45 Third, they alleged that the initiative created a taxpayerfunded entity that was not under the direct control of the state as required.46 Fourth, they
alleged that the Independent Citizens’ Oversight Committee (ICOC) had an inherent conflict
of interest because it would both award grants and include representatives of institutions
that might receive grants.47 The trial court rejected these allegations, as did the appellate
court.48
E. The Proposition
1. Effects of Proposition 14
If approved, Proposition 14 will allow for the issuance of $5.5 billion in general
obligation bonds.49 These bonds will be used to continue funding stem cell and other vital
37
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research to develop treatments and cures for serious diseases and conditions.50 Proposition
14 will also set aside $1.5 billion for research and therapy of brain and central nervous
system diseases.51
2. Differences Between Proposition 14 and Proposition 71
Although much of the text is substantially the same, Proposition 14 not only renews
this funding, but adds and updates the programs implemented by Proposition 71.52 There
are four major updates.53 First, Proposition 14 makes changes to improve access to
therapies for California patients with insufficient funds, establishing an additional working
group to focus on this effort.54 Second, it increases the number of members on the ICOC
from 29 to 35.55 Third, it caps the number of bond-funded, full-time CIRM employees at 70,
with an additional 15 dedicated to improving access to stem-cell-derived therapies and
treatments.56 Fourth, it establishes training programs for undergraduate students and
fellowships for graduate students related to advanced degrees and technical careers in
stem cell research, treatments, and cures.57
Currently CIRM has three working groups that advise the ICOC, one each for
medical research funding, research standards, and facilities grants.58 Proposition 14 will
create a fourth working group that will focus on improving access to treatments and cures.59
It will also increase ICOC public meetings from two to four per year and place restrictions
on the royalty revenues received through intellectual property agreements that go to the
General Fund.60 The royalties will be used to offset the costs to California patients who have
insufficient means to purchase the treatment from institute-funded research instead of being
used for other General Fund items.61
Under Proposition 14, the additional members of the ICOC will include a faculty
member, physician/scientist, researcher, or executive officer from the UCSF Fresno/Clovis
campus to promote geographic diversity and access; an additional member may be
appointed by the Governor from the California State University system who has an
advanced degree in biological sciences; the Governor and Lieutenant Governor each shall
appoint an additional member that will include someone from a mental health conditions
50
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background; and the Treasurer and Controller shall each appoint a nurse with experience
in clinical trial management and/or stem cell or genetic therapy delivery.62 Additionally, the
initiative imposes a new employee cap of 70 that does not include members of the ICOC
and 15 additional employees designated for the development of policies and programs to
help make treatments available and affordable for Californians.63
If approved, Proposition 14 will establish a scientific advisory task force to provide
expert guidance to address specific objectives in areas under the institute’s jurisdiction,
including scientific, policy, ethical, financial, and technical matters.64 The Chair and the
President shall each appoint an equal number of members with expertise in the area for
which advice is sought, including at least one member with a patient advocate
perspective.65
The initiative also amends Proposition 71 by adding additional accountability
requirements that the ICOC shall update, at its discretion.66 These include the standards
relating to conflict of interest rules, ethical research and treatment, and independent
financial audits, to be generally aligned with standards adopted by the National Academy
of Sciences.67
F. Path to the Ballot
After helping to draft the proposition, Robert N. Klein filed the ballot initiative on
October 10, 2019.68 Though the proponents did suspend signature gathering due to the
coronavirus pandemic, on May 5, 2020, the proponents submitted 924,216 signatures for the
ballot initiative.69 Only 623,212 valid signatures were required.70
G. Where the Money Goes and How It is Decided
Proposition 14 includes several rules and guidelines how the $5.5 billion will be
allocated.71 First, at least $1.5 billion of the $5.5 billion is reserved for grants for research
and therapy for Alzheimer’s, Parkinson’s, stroke, epilepsy, and other brain and central
nervous system diseases and conditions.72 Second, royalty revenues received through
intellectual property agreements resulting from grants and loans awarded under
62
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Proposition 14 will be placed in an interest-bearing account in the General Fund.73 That
amount and its interest will be used to offset the costs of providing treatments and cures
from institute-funded research to California patients with insufficient means.74
The rest of the proceeds of the bonds sold for Proposition 14 will be divided by
certain percentage parameters. First, no less than 95.5% of the proceeds will be used for
grants and grant oversight.75 Of the 95.5%, no less than 98% of those proceeds will be used
for research, therapy development, and therapy delivery grants.76 The other up to 2% of
those proceeds will be used for research consulting in support of access to and
affordability of treatments and cures.77
The ICOC determines the amounts of the grants and to whom they are given.78
Members of the ICOC are not allowed to participate in or influence decisions regarding
approval of grants for their employers, though they may participate in decisions awarding
grants for the purpose of research involving a disease from which a family member is
suffering or in which they have interests as representatives of disease advocacy
organizations.79 Since it began granting funds in 2006, CIRM has recorded and published
each grant, listing the grant type, the grant title, the institution with which the researcher is
associated, the researcher’s name, the award amount, the disease focus (beginning in
2007), the type of stem cell used (beginning in 2007), the grant number, the award’s status,
and the start and end dates.80
The remaining 4.5% of the proceeds have more flexibility. Up to 3% of the proceeds
may be used for the implementation costs of research and research facilities, which include
development, administration, and oversight of the grant-making process.81 Up to 3% of the
proceeds will be used for costs of general administration of CIRM.82 Up to 1% of the
proceeds may be used to pay for up to 15 full-time employees for CIRM.83
Additionally, Proposition 14 contains provisions that require grantees that gain
revenue from their institute-funded projects to pay certain amounts back to the General
Fund, dependent on factors such as the amount of revenue received, whether funding
sources other than CIRM directly contributed to the development of the therapy or
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technology, and whether the grantee self-commercializes a product resulting from an
invention that arises from research funded by CIRM.84
III.

DRAFTING ISSUES
A. Ambiguous Terms

Proposition 14 includes a clause requiring no more than 1% of proceeds be used to
pay for up to 15 full-time employees “over 10-15 or more years.”85 The drafters state that this
was left ambiguous to allow for these employees to be retained after other funding runs out
to help wind down the ongoing grants, if necessary.86 Another vague provision is the
additional accountability requirement, which is framed as a requirement, but only requires
that the ICOC update its standards relating to conflict of interest rules, ethical research and
treatment, and independent financial audits at its discretion to be generally aligned with
standards adopted by the National Academy of Sciences.87
Further, in the additions regarding CIRM’s plan to assist California patients in
obtaining therapies if those patients have insufficient funds, Proposition 14 does not include
a definition of a “California patient” or how “insufficient funds” will be determined. This
could cause confusion regarding (1) whether patients must be California residents to
receive assistance, and, if so, for how long they must be residents, and (2) whether one’s
funds are sufficiently “insufficient” to qualify for assistance. The drafters of the proposition
note that this was done intentionally to leave that determination to the state and the board
of CIRM.88
B. Severability Clause
If any provisions of the text are found invalid, Proposition 14 includes a severability
clause allowing the valid provisions to remain.89 The majority of the text of Proposition 14 is
similar to the text in Proposition 71, none of which has been held invalid. Though there are
new added and amended provisions, they are not similar to the types of provisions that
have been held invalid in other circumstances, as discussed below, and it is unlikely that
Proposition 14 will have any invalid parts that are struck down.
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IV.

CONSTITUTIONAL AND STATUTORY ISSUES
A. Federal Constitution

The Commerce Clause of the Constitution grants Congress the power to regulate
interstate commerce.90 Because of this power, states cannot pass legislation that
discriminates against or excessively burdens interstate commerce.91 The federal government
has a particular interest in preventing states from enacting policies that favor citizens or
businesses of that state at the expense of non-citizens conducting business within that
state.92 However, when the state is acting as a business, these preferential policies are
allowed.93 This is called the market participation exception.94
Here, CIRM has been established to be an institution under the “exclusive
management and control of the State,” so its structure and actions affecting the market
could be attributable to California.95 Proposition 14 includes a provision which requires the
ICOC to “establish standards to ensure that grantees purchase goods and services from
California suppliers to the extent reasonably possible, in a good faith effort to achieve a
goal of more than 50 percent of such purchases from California suppliers,” a provision
which, on its face, seems to favor businesses within the state.96 However, by purchasing
goods and services, CIRM acts business in the marketplace, and thus it is likely the market
participation exception applies and Proposition 14 does not violate the Constitution.
B. State Constitution
1. General Obligation Bonds
State general obligation bonds allow the state of California to borrow money from
investors to fund public works projects.97 The state commits to repay the bonds using the
state General Fund and requires a majority of voters to approve general obligation
bonds.98 After selling the bonds the state makes regular payments over time until the bonds
are paid off.99
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As of 2020, the state has about $80 billion in General-Fund-supported bonds that it is
making annual principal and interest payments on, and it is estimated that the state is
paying $7 billion annually from the General Fund to repay these bonds.100 The voters and
legislature have approved around $38 billion bonds that have yet to be sold.101 If voters
approve Proposition 14, it is projected to increase the portion of the state’s annual General
Fund revenues that are set aside to pay for bond debt, the debt-service ratio, by about onefifth of one percentage point compared to what it would otherwise have been over the next
couple of years.102
2. Single-Subject Rule
The California Constitution requires voter initiatives to have a single subject.103 The
provisions of the initiative must be reasonably germane to each other.104 The phrase
“reasonably germane” requires that the provisions have a reasonable and common-sense
relationship among their various components in furtherance of a common purpose.105
There were two lawsuits challenging the constitutionality of Proposition 71. As a
result, California’s First District Court of Appeal held, in part, that Proposition 71 did not
violate the single-subject rule.106 In that case, the court determined the trial court was
correct in finding that the overarching subject of Proposition 71 was stem cell research and
funding and that the other portions such as the development of the ICOC, inclusion of
“other vital research opportunities” catch-all, and other administrative sections were
reasonably interrelated and do not violate the single-subject rule.107 Because Proposition 14
is an update and renewal of Proposition 71, most of the text is the same, and therefore that
text almost certainly meets the single-subject rule. Proposition 14 does add new
considerations regarding efforts to prioritize some funding for
California patients who would otherwise have insufficient funds, but based on previous case
law, it seems likely those additions would be ‘reasonably germane’ to the overarching
subject of stem cell research and funding.
V.

PUBLIC POLICY ISSUES
A. Proponents’ Arguments

On the whole, the proponents essentially assert that the research performed due to
projects that CIRM helped fund has been saving and changing lives and that Proposition 14

100
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would help sustain those projects and begin new ones.108 The Yes on 14 campaign states
that Proposition 71 has led to more than 90 clinical trials, two FDA-approved drugs for the
treatment of two forms of fatal blood cancers, and over 2,900 published medical
discoveries.109 Further, proponents assert that CIRM-assisted research has led to some other
promising cancer therapies that have reversed, over the course of two years, 80% mortality
rates to 85% survival rates starting in stage four patients.110 There are over 800 patents
pending for CIRM-funded discoveries, which proponents add would be a future source of
state revenue.111 They have added that this proposition is necessary to continue supporting
ongoing trials and refining and testing discoveries.112 Additionally, proponents add that,
while many of the treatments are still in the early stages of clinical trials, there have been
the following improvements to individuals lives: cancer patients who had exhausted all
other therapies are now in remission; paralysis patients have regained upper body function;
blind patients are regaining their eyesight; a cure has been developed for the once-fatal
“bubble baby” disease; patients with Type 1 Diabetes have begun producing their own
insulin; and multiple clinical trials are underway for leukemia, non-Hodgkin lymphoma,
ovarian cancer, and more.113
Other supporters of this proposition include the University of California Board of
Regents; members of the Yes on 14 coalition: Californians for Stem Cell Research,
Treatments & Cures, which includes over 83 patient advocate organizations, several other
organizations and individuals, including several Nobel Prize winners.114 One notable group
that supports Proposition 14 is Seth and Lauren Rogen’s Hilarity for Charity non-profit, which
the two created because Lauren Rogen’s mother suffered from Alzheimer’s; Seth Rogen
even voiced a character called Stemmy the Stem Cell in a promotional video for Yes on
14.115
Another factor proponents, within and without CIRM and its grantees, note is the
draw the potential for future scientific advancements, stating that the state’s funding attracts
the best minds to contribute to the field of science and perhaps to establish their own
businesses here; this benefits California’s economy and citizens, as well as the citizens of
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this nation and others.116 According to some, Proposition 71 has made the state the “center
of the stem cell universe.”117 Proponents are concerned that potential consequences of this
funding not being renewed include the state’s loss of revenue and prestige regarding jobs,
intellectual property, and leadership in the science sector.118 If Proposition 14 is not
approved, CIRM will take further planned steps to wind down the program, including
reducing its staff.119
B. Opponents’ Arguments
Opponents of the proposition argue that CIRM has issues regarding conflicts of
interest and a lack of legislative oversight.120 These claims appear to be similar to the
claims that were dismissed by the courts in the California Family Bioethics Council case
regarding Proposition 71.121 However, opponents assert that Proposition 14 further adds to
those concerns by “outsourc[ing] critically important decisions about ethical standards to an
unaccountable national committee.”122 Presumably, opponents make this argument because
the proposition adds a provision regarding additional accountability requirements that
require the ICOC to update its standards relating to conflict of interest rules, ethical
research and treatment, and independent financial audits at its discretion “to be generally
aligned with standards adopted by the National Academy of Sciences to the extent that
such standards are consistent with constitutional and statutory requirements applicable to
the institute.”123 Opponents further argue that the ICOC is too large at 29 members, so they
dislike the addition of 6 more members.124 Regarding conflicts of interest in particular,
opponents acknowledge that members of the ICOC cannot participate in votes to grant
money to their own institutions, but they state that “the appearance of rampant conflicts is
inescapable.”125
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Opponents also note that the original rationale for this funding, the fact that the
federal government had restricted funding for stem cell research at the time Proposition 71
was passed, has been eliminated because most of the federal funding restrictions have
been lifted.126 They also state that the two cancer treatments CIRM helped fund did not use
embryonic stem cells, so they could have been federally funded even under the previous
restrictions.127 They also argue that voting on this sort of investment should be stalled until
after the election, asserting that, if Democrats get more power, there should be growing
support for embryonic stem-cell research at the federal level, which is from where they
argue such funding should originate.128
Opponents also assert that private industry has stepped up, though this seems to be
difficult to substantiate.129 Proponents respond to that argument by noting that private
industry, due to its focus on financial return, is unlikely to fund high-risk projects, while
government agencies can fund research with a focus on benefits to the public rather than
on making money.130
The named opponent on the California Voter Information Guide, John Seiler, asserts
that the state cannot afford Proposition 14 “during this economic and budget crisis” and
CIRM has “management challenges and poor results.”131 He also argues that “[s]ervicing
debt of Prop. 14 could increase pressure for higher taxes or layoffs of nurses, first
responders and other public employees.”132 When contacted for further information, he did
not provide sources that proved these claims.
Right to Life of Central California, one opponent of Proposition 14, is a pro-life nonprofit that is focused on activities such as having its employees and volunteers speak with
individuals entering and leaving Planned Parenthood and “defend[ing] the sanctity of all
human life.”133 Right to Life of Central California states that it is against embryonic stem cell
research as a whole because they believe it cheapens human life and is irresponsible
spending.134 They argue that the human embryos used in some of the research funded by
CIRM are unique human organisms, and their use for research instrumentalizes human
life.135 They also argue that it is a waste of money because the public has not yet seen the
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benefits of this research, though this can be contradicted by the proponents’ list of
accomplishments above.136 They state they would not
support CIRM unless it exclusively turned to adult stem cells and induced pluripotent stem
cells, which are derived from skin or blood cells and reprogrammed back into an
embryonic-like state.137
C. Campaign Finance
1. Proponents
There is a political action committee titled “Yes on 14: Californians for Stem Cell
Research, Treatments and Cures.”138 As of September 22, 2020, it has received
$6,605,389.51 in contributions and has spent $6,919,032.06.139 The largest donor is Robert N.
Klein II (Klein Financial Corporation), contributing a total of $4,628,924.51, in-kind
contributions making up $4,503,924.51 of that amount.140 Other top donors include Juvenile
Diabetes Research Foundation, Open Philanthropy Action Fund, Ann S. Tsukamoto, and One
Mind for Research, Inc. Juvenile Diabetes Research Foundation describes itself as the
leading global organization funding type 1 diabetes research.141 Open Philanthropy Action
Fund is a 501(c)(4) social welfare organization.142 Ann S. Tsukamoto is a doctor who has
spent over 20 years working in stem cell biology, and her work has led to many
advancements, including in comprehending the blood systems of cancer patients.143 One
Mind for Research is a non-profit organization that focuses on encouraging developments in
brain health.144
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2. Opponents
Though there is a political action committee for No on Proposition 14 registered with
the California Secretary of State, it has not yet recorded any filings.145 We have not found
any readily available evidence about campaign contributions the named opponent, John
Sieler, has made.146
D. Fiscal Considerations
Proposition 14 has an estimated total cost, including interest, of approximately $7.8
billion, equaling an average of about $260 million per year over 30 years; this is about 4%
more than the state currently spends from the General Fund on its bond debt.147
An economic impact study, funded by CIRM, focused on the various economic
impacts of CIRM over and above its main functions of improving health and well-being.148
The increases in economic output, employment and tax revenues represent valuable cobenefits of CIRM activities.149 Such benefits emanate not only from CIRM direct funding
commitments but also from co-funding, partnership funding, follow-on funding, and
additional leveraged funding.150 Not only the direct impacts but also various indirect
impacts were quantified as CIRM and related expenditures ripple throughout the
economy.151
The report estimated that the total impacts of CIRM to date on the California
economy have been: $10.7 billion of additional gross output (sales revenue); $641.3 million
of additional state and local tax revenues; $726.6 million of additional federal tax revenues;
and 56,549 additional full-time equivalent jobs, half of which offer salaries considerably
higher than the state average.152 Additionally, the report determined that the impact on the
economy of the rest of the U.S. has been: $4.7 billion of additional gross output; $198.7
million of additional state and local tax revenues; $208.6 million of additional federal tax
revenues; and 25,816 additional jobs.153
Another consideration is that, under Proposition 14, the bonds are to be sold over a
period of no less than 10 years, with the cost of the bonds spread over 40 years so that the
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repayment is aligned with the period of time over which California patients are expected to
benefit from institute-funded research.154
VI.

CONCLUSION

Proposition 14 updates and renews the stem cell research program approved by
Californian voters in 2004 (Proposition 71). Proposition 14 grants $5.5 billion in bonds for
projects related to stem cell and other medical research aimed at developing treatments
and cures for serious diseases such as diabetes, cancer, and heart disease, among many
others.155 Over the years, many researchers have relied on this funding to perform studies
and begin over 90 clinical trials, and it has led to two FDA-approved drugs to treat fatal
blood cancer and over 2,900 published medical discoveries.156 Among other adjustments to
the previous program such as increasing the number of members on the ICOC, Proposition
14 adds an emphasis on supporting California patients with insufficient funds.
The proponents argue that this funding will continue to support innovation, develop
therapies and cures for patients with serious diseases, and help maintain the jobs and
prestige state-assisted stem cell research has brought to California. The opponents argue
that Proposition 14 does not address their concern with CIRM’s lack of legislative oversight
and potential conflicts of interest, though the California courts dismissed these concerns
regarding Proposition 71 and Proposition 14 does contain safeguards for managing
conflicts of interest. The opponents also argue that there is no longer as much of a need for
this funding because the federal government has removed many of its previous restrictions
on funding stem cell research.
A “yes” vote for Proposition 14 will allow the state to provide $5.5 billion in bonds for
stem cell and other medical research, renewing and updating the program that has been
in place since 2004.
A “no” vote for Proposition 14 will not allow the state to provide $5.5 billion in bonds
for stem cell and other medical research, and the current program will end after spending
its remaining funding on projects to which it has already allocated money and completing
its employment of CIRM staff members.
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